A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting

BMC Infectious Diseases

Edward A Belongia¹  Jennifer K Meece¹  Maria E Sundaram¹  Jeffrey J VanWormer¹ 

[1] Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, 1000 North Oak Ave, 54449 Marshfield, WI, USA

关键词: Influenza;    Symptom severity;    Acute respiratory illness;   

Others  :  1133970
DOI  :  10.1186/1471-2334-14-231

 received in 2014-01-06, accepted in 2014-04-25,  发布年份 2014

【 摘 要 】

Background

Acute respiratory infections (ARIs) are common in outpatient practice, and the severity of symptoms contributes to the overall burden of illness. We examined the association between a subjective symptom severity score, demographic and clinical characteristics, and presence of laboratory-confirmed influenza among central Wisconsin adults who sought care for ARI during four influenza seasons. We hypothesized that adults with laboratory-confirmed influenza would rate their symptoms as more severe relative to adults without influenza, and vaccinated adults with influenza would rate symptoms as less severe than those who were not vaccinated.

Methods

Patients with acute respiratory illness, including feverishness or cough symptoms ≤ 7 days duration, were prospectively enrolled and tested for influenza by reverse transcription polymerase chain reaction (RT-PCR) during influenza seasons 2007–08 through 2010–11. Perceived severity was self-rated during the enrollment interview for eight symptoms, on a scale of 0 (absent) to 3 (severe). Scores for each symptom were summed to generate a combined severity score ranging from 1 to 24 for each individual. The association between influenza test result and severity score was examined using linear regression.

Results

There were 2,374 individuals included in the analysis, including 324 with RT-PCR confirmed influenza. The mean symptom severity score was 12.3 (±4.1) points, and the most common symptoms were cough (92%), fatigue (91%), and nasal congestion (84%). In the final adjusted model, influenza infection was the strongest independent predictor of higher severity score, with a mean increase of 1.7 points compared to those who were influenza negative (p < 0.001). Among adults with influenza, the association between influenza vaccination and symptom severity was modified by age (p < 0.001). In adults ≥ 65 years old with RT-PCR confirmed influenza, symptom severity was 31% lower in those who were vaccinated as compared to those who were not vaccinated.

Conclusions

Influenza is associated with more severe symptoms of acute respiratory illness. The association between influenza vaccination and reduced symptom severity in older adults should be confirmed and explored further in other populations and seasons.

【 授权许可】

   
2014 VanWormer et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Denny FW: The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 1995, 152:S4-S12.
• [2]Heikkinen T, Jarvinen A: The common cold. Lancet 2003, 361:51-59.
• [3]Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, Louie J, Doyle TJ, Crockett M, Lynfield R, Moore Z, Wiedeman C, Anand M, Tabony L, Nielsen CF, Waller K, Page S, Thompson JM, Avery C, Springs CB, Jones T, Williams JL, Newsome K, Finelli L, Jamieson DJ, Pandemic H1N1 Influenza in Pregnancy Working Group: Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303(15):1517-1525.
• [4]Varner MW, Rice MM, Anderson B, Tolosa JE, Sheffield J, Spong CY, Saade G, Peaceman AM, Louis JM, Wapner RJ, Tita AT, Sorokin Y, Blackwell SC, Prasad M, Thorp JM Jr, Naresh A, Van Dorsten JP, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU): Influenza-like illness in hospitalized pregnant and postpartum women during the 2009–2010 H1N1 pandemic. Obstet Gynecol 2011, 118(3):593-600.
• [5]Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, et al.: Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010, 10:521-526.
• [6]Centers for Disease Control and Prevention (CDC): 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care – New York City, 2009. Morb Mortal Wkly Rep 2010, 59(11):321-326.
• [7]Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, Chu SY, Sackoff JE, Jamieson DJ, Fine AD, Shapiro-Mendoza CK, Jones LE, Uyeki TM, Balter S, Bish CL, Finelli L, Honein MA: Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010, 115:717-726.
• [8]Schanzer DL, Schwartz B: Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontari, Canada. Acad Emerg Med 2013, 20(4):388-397.
• [9]Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, Jeremiah C, Knox J, Lane GP, Tramontana AR, Slavin MA, Schulz TR, Richards M, Birch CJ, Cheng AC: Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010, 192:84-86.
• [10]Centers for Disease Control and Prevention (CDC): Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009. Morb Mortal Wkly Rep 2010, 58(51 & 52):1436-1440.
• [11]Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK: Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012, 206(1):56-62.
• [12]Elliot AJ, Cross KW, Fleming DM: Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990–2005. J Public Health (Oxf) 2008, 30(1):91-98.
• [13]Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, Chuang JH, Kuo HS, Chang SC: Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010, 60(2):168-174.
• [14]Gran JM, Kacelnik O, Grjibovxki AM, Aavitsland P, Iversen BG: Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1) pdm09 with estimated excess mortality. Influenza Other Respi Viruses 2013. [Epub ahead of print]
• [15]Fowlkes A, Dasgupta S, Chao E, Lemmings J, Goodin K, Harris M, Martin K, Feist M, Wu W, Boulton R, Temte J, Brammer L, Finelli L: Estimating influenza incidence and rates of influenza-like illness in the outpatient setting. Influenza Other Respi Viruses 2012. Epub ahead of print
• [16]Li S, Leader S: Economic burden and absenteeism from influenza-like illness in healthy households with children (5–17 years) in the US. Respir Med 2007, 101(6):1244-1250.
• [17]Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB: The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25(27):5086-5096.
• [18]Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, Vandermause M, LIndstrom S, Kempf D, Shay DK: Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008–2009 (H1N1), and 2007–2008 (H3N2) infections. JAMA 2010, 304(10):1091-1098.
• [19]Sauro A, Barone F, Blasio G, Russo L, Santillo L: Do influenza and acute respiratory infective diseases weigh heavily on general practitioners’ daily practice? Eur J Gen Pract 2006, 12(1):34-36.
• [20]Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN: Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18(2):274-280.
• [21]Castilla J, Godoy P, Dominguez A, Martinez-Baz I, Astray J, Martin V, Delgado-Rodriguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T, CIBERESP Cases and Controls in Influenza Working Group Spain: Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013, 57(2):167-175.
• [22]Turner RB: Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 1997, 78:531-539.
• [23]Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK: Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: comparison of interim and final results. Vaccine 2011, 29(38):6558-6563.
• [24]Hernes SS, Quarsten H, Hagen E, Lyngroth AL, Pripp AH, Bjorvatn B, Bakke PS: Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs. Eur J Clin Microbiol Infect Dis 2011, 30(2):159-165.
• [25]Centers for Disease Control and Prevention NCfIaRD: Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus - United States, 2009. Morb Mortal Wkly Rep 2009, 58:826-829.
• [26]Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA: Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009, 27(47):6546-6549.
• [27]Cody RP, Smith JK: Applied Statistics and the SAS Programming Language. New York, NY: Prentice Hall; 2005.
• [28]Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E: Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37(2–3):427-439.
• [29]Zhou X, McElhaney JE: Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011, 29(11):2169-2177.
• [30]Jackson GG, Dowling HF, Anderson TO, Riff L, Saporta J, Turck M: Susceptibility and immunity to common upper respiratory viral infections: the common cold. Ann Intern Med 1960, 55:719-738.
• [31]Farr BM, Gwaltney JM, Hendley JO, Hayden FG, Naclerio RM, McBride T, Doyle WJ, Sorrentino JV, Riker DK, Proud D: A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990, 162(5):1173-1177.
• [32]Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK: Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996, 275(4):295-299.
• [33]MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group: Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. From the MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998, 352(9144):1877-1881.
• [34]Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH: Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000, 133(4):245-252.
• [35]Nicholson KG, Aoki FY, Osterhaus ADM, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P: Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000, 355:1845-1850.
• [36]Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK: Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ 2005, 173(9):1043-1048.
• [37]Pach D, Knochel B, Ludtke R, Wruck K, Willich SN, Witt CM: Visiting a sauna: does inhaling hot dry air reduce common cold symptoms? A randomised controlled trial. Med J Aust 2010, 193:730-734.
• [38]Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, Stauffacher EA: The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract 2002, 51(3):265.
• [39]Pronk NP, Crain AL, Vanwormer JJ, Martinson BC, Boucher JL, Cosentino DL: The use of telehealth technology in assessing the accuracy of self-reported weight and the impact of a daily immediate-feedback intervention among obese employees. Int J Telemed Appl 2011, 2011:909248.